SG Hiscock and Company say the Omicron variant has not stifled their four investment themes and may instead present opportunities for their positionings....
It will invest in Australian medical technology companies, with a social impact focus....
After decades of underperformance, value is seeing a turnaround and outpacing growth stocks for the first time in years, writes Laura Dew....
It would be a mistake to assume inflation will remain low, writes Hamish Tadgell, so advisers need to position portfolios to protect against this threat....
With the exception of the Global Financial Crisis, most cycles required only a three-year earnings recovery, according to SG Hiscock....
The reporting season has highlighted the divergence between firms with resilient business models, quality brand names, and the ability to capitalise on online demand, and...
Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...
This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...
Interesting. Would be good to know the details of the StrategyOne deal....